
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1052 | 1029 | 1153 | 1306 | 1518 | 1859 |
Fund Return | 5.19% | 2.91% | 15.29% | 9.3% | 8.7% | 6.39% |
Place in category | 181 | 205 | 197 | 71 | 97 | 37 |
% in Category | 37 | 46 | 45 | 18 | 25 | 13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Royal London FTSE 350 Tracker Fund | 5.17B | 6.31 | 9.09 | 6.25 | ||
Royal London FTSE 350 Tracker Z Fun | 5.17B | 6.34 | 8.96 | 6.20 | ||
Royal London European Growth Fund C | 2.52B | 9.80 | 9.59 | 8.15 | ||
Royal London US Tracker Z Fund Accu | 1.25B | -1.33 | 14.21 | 14.47 | ||
Royal London UK Equity Income A | 1.15B | 5.12 | 8.81 | 5.78 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GB00B2PLJH12 | 2.04B | 6.61 | 10.97 | 7.28 | ||
TB Evenlode Income B Income | 3.01B | 3.59 | 6.59 | 7.84 | ||
UK Equity Income Fund Institutional | 86.3M | 3.09 | 8.21 | 6.55 | ||
UK Equity Income Fund Retail Income | 131.89M | 3.04 | 7.62 | 5.96 | ||
UK Equity Income Fund Retail Accumu | 111.63M | 1.63 | 8.03 | 5.61 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shell | GB00BP6MXD84 | 6.93 | 33.58 | -1.48% | |
AstraZeneca | GB0009895292 | 4.46 | 11,416.0 | +1.97% | |
Relx | GB00B2B0DG97 | 4.18 | 3,887.00 | +0.70% | |
Unilever | GB00B10RZP78 | 3.91 | 54.86 | +1.22% | |
British American Tobacco | GB0002875804 | 3.72 | 3,124.0 | +0.61% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Neutral | Sell |
Technical Indicators | Strong Buy | BUY | Strong Buy |
Summary | Neutral | Neutral | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review